Search results
Bansal Wire IPO booked nearly 4 times on Day 2. Check GMP and other details - The Economic Times
The Economic Times· 3 hours agoThe initial public offer (IPO) of Bansal Wire was subscribed nearly 4 times so far on the second day...
Where to Watch the 4th of July Fireworks in Washington, DC
Conde Nast Traveler· 2 hours agoEntry for the event is free for all with an RSVP, with preferred seating reserved for hotel guests....
Ambey Laboratories IPO subscribed over 7x on the first day of bidding so far. Check GMP,...
Livemint· 5 hours agoAmbey Laboratories, with 40 years in agrochemicals, is offering IPO at ₹65-68 per share. The net...
Effwa Infra IPO to open on July 5; price band set at ₹78 to ₹82 apiece. Check GMP. | Stock Market...
Livemint· 3 hours agoEffwa Infra IPO comprises fresh issue of 5,316,800 equity shares and offer-for-sale of 936,000...
Emcure Pharma IPO Day 2: Check Subscription Status, GMP Today - News18
News18· 7 hours agoEmcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which was opened for...
5 stock market myths in a raging bull market: Kotak Equities - The Economic Times
The Economic Times· 3 hours agoThe myths listed by it include one that says that Indian markets are trading at reasonable...
Bansal Wire IPO second day of bidding today: Should you buy or not? Check GMP, key dates,...
Livemint· 9 hours agoBansal Wire IPO subscription status: On the first day of bidding yesterday, Wednesday, July 3, the...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 26 minutes agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital, raised ₹583 crore from anchor investors prior to its IPO launch. The IPO garnered ...
Where to Watch the Chicago Fourth of July Fireworks 2024
Conde Nast Traveler· 20 hours agoAll admission passes include access from 9 a.m. to 11 p.m., and you can spring for an all-access...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 6 hours agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...